Skip to content
AnalystLens

Omega Healthcare Investors 8-K Report, Shareholder Vote Results (Jun 5, 2026)

Reports
Shareholder Matters·Other Events
Filing Date
Filed June 5, 2026
Period End
June 5, 2026
Security
OHI
In the record · 2016–202610-K1210-Q348-K126

OHI filed 12 annual reports (10-K), 34 quarterly reports (10-Q) and 126 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Jan ’17Jan ’17
  2. Material agreement8-K · Feb ’19Feb ’19
  3. Leadership change8-K · Aug ’21Aug ’21
  4. Material agreement8-K · Jun ’25Jun ’25

Summary

Summary of the 8-K filed June 5, 2026. Cited figures are marked; the original filing is the authoritative source.

Omega Healthcare Investors, Inc. held its 2026 Annual Meeting of Stockholders on June 5, 2026, with holders of 255,926,290 common shares present in person or by proxy, representing approximately 85.93%a of total outstanding common stock as of the record date.

All three proposals passed: all eight director nominees (Kapila K. Anand, Craig R. Callen, Dr. Lisa C.

Egbuonu-Davis, Barbara B. Hill, Kevin J. Jacobs, C.

Taylor Pickett, Stephen D. Plavin and Burke W. Whitman) were elected, Ernst & Young LLP was ratified as independent registered public accounting firm for the year ending December 31, 2026 (240,521,117 for versus 14,949,017 against), and executive compensation was approved on an advisory basis (202,883,780 for versus 10,248,851 against).

Under Item 8.01, the company updated its beneficial ownership disclosure for holders of more than 5%b of its common stock. The filing explains that The Vanguard Group filed an amendment to its Schedule 13G on March 27, 2026, reporting it no longer had or was deemed to have beneficial ownership following an internal corporate realignment, and that two affiliated Vanguard entities subsequently reported beneficial ownership on a disaggregated basis.

As of April 8, 2026, the filing lists BlackRock, Inc. with 31,867,200 shares (10.7%c of class; 10.1% including common stock equivalents), Vanguard Portfolio Management with 27,160,324 shares (9.1%; 8.6%), and Vanguard Capital Management with 15,689,615 shares (5.3%; 5.0%). The company reported 297,799,835 common shares and 16,284,278 common stock equivalents (including OP Units) outstanding on that date.

Key Highlights

  1. Annual Meeting held June 5, 2026, with holders of 255,926,290 shares (approximately 85.93% of outstanding common stock as of the record date) present or represented by proxy
  2. All eight director nominees elected; Kapila K. Anand received 207,267,529 FOR votes and Stephen D. Plavin received 198,442,058 FOR votes, the lowest director support level in the filing
  3. Ernst & Young LLP ratified as independent registered public accounting firm for fiscal year ending December 31, 2026, with 240,521,117 FOR and 14,949,017 AGAINST
  4. Advisory vote on executive compensation approved with 202,883,780 FOR and 10,248,851 AGAINST
  5. Vanguard Group's March 27, 2026 Schedule 13G amendment reflected an internal corporate realignment, after which two affiliated Vanguard entities reported over 5% ownership on a disaggregated basis
  6. BlackRock, Inc. is the largest reported 5% holder at 31,867,200 shares, or 10.7% of class (10.1% including common stock equivalents)
  7. As of April 8, 2026, 297,799,835 common shares and 16,284,278 common stock equivalents (including OP Units) were outstanding

Frequently Asked Questions

  1. Were any of the company's director nominees or proposals rejected by stockholders?

    No. The filing states that each director nominee was elected, the selection of Ernst & Young LLP was ratified, and executive compensation was approved on an advisory basis. Stephen D. Plavin received the most AGAINST votes among nominees at 15,286,082.

  2. Why did the company update its beneficial ownership information for 5% holders?

    The Vanguard Group filed an amendment to its Schedule 13G on March 27, 2026, reporting that it no longer had or was deemed to have beneficial ownership of the company's shares following an internal corporate realignment. After the proxy statement was filed, two affiliated Vanguard entities reported beneficial ownership of more than 5% on a disaggregated basis, and the company updated its disclosure to reflect the most current Schedule 13G filings.

  3. Who are the largest reported beneficial owners of Omega's common stock?

    As of April 8, 2026, BlackRock, Inc. reported 31,867,200 shares (10.7% of class), Vanguard Portfolio Management reported 27,160,324 shares (9.1%), and Vanguard Capital Management reported 15,689,615 shares (5.3%). BlackRock's figure is based on a Schedule 13G/A filed April 30, 2025, while the Vanguard figures are based on Schedule 13G filings made April 29 and April 30, 2026.

  4. How many shares were represented at the Annual Meeting?

    Holders of 255,926,290 shares of common stock were present in person or represented by proxy, representing approximately 85.93% of total outstanding common stock as of the record date. The filing also reports 41,826,987 broker non-votes on the director elections and executive compensation proposal.